Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Flunarizine as a Candidate for Drug Repurposing Against Human Pathogenic Mammarenaviruses

Viruses(2025)10.3390/v17010117Source: DataRank Database

Flunarizine as a Candidate for Drug Repurposing Against Human Pathogenic Mammarenaviruses is a research paper published in Viruses (2025). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 3.98)OA: goldTopics (44)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Ikemefuna C. Uzochukwu ORCID,Fortunatus C. Ezebuo ORCID,InnocentMary Ejiofor,Mercy Adebola,Innocent N. Okpoli ORCID

Live enrichment

PubMed:39861906 PMC:PMC11768584 OpenAlex:https://openalex.org/W4406472515

TETFUND/NRF

Grant: TETFund/DR&D/CE/NRF/STI/24/Vol1

TETFUND/NRF

Grant: AI125626

TETFUND/NRF

Grant: AI128556

NIAID NIH HHS

Grant: R21 AI128556

TETFUND/NRF

Grant: TETFund/DR&D/CE/NRF/STI/24/Vol1

NIAID NIH HHS

Grant: R01 AI125626

National Institutes of Health

Grant: 1R01AI125626-01A1

A Virus-Free Cell Platform To Discover Inhibitors Of Lassa Fever Virus

National Institutes of Health

Grant: 5R21AI128556-02

Modulation of Lassa Virus vRNP Activity By Host Cell Factors

FWCI

3.98

Citation Percentile

0.9%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1999-4915/17/1/117/pdf?version=1737014803

publisherhttps://www.mdpi.com/1999-4915/17/1/117/pdf?version=1737014803

publisherhttps://www.mdpi.com/1999-4915/17/1/117/pdf

journalhttps://doi.org/10.3390/v17010117

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39861906

Fields of Study

Viral Infections and Outbreaks ResearchViral gastroenteritis research and epidemiologyHepatitis B Virus Studies0301 basic medicine03 medical and health sciences

MeSH Terms

AnimalsAntiviral AgentsCell LineChlorocebus aethiopsFlunarizineHumansLassa FeverLassa virusVero CellsViral ProteinsVirus ReplicationDrug RepositioningMolecular Docking Simulation

Keywords

Drug repositioningVirologyIn silicoFlunarizinePharmacologyMedicineDrugBiologyAntiviralMinigenomeLassa VirusLcmvIn Silico DockingBiology and Life SciencesVirus ReplicationMicrobiologyAntiviral AgentsQR1-502ArticleCell LineMolecular Docking SimulationViral ProteinsLassa FeverChlorocebus aethiopsHumansAnimals

Flunarizine as a Candidate for Drug Repurposing Against Human Pathogenic Mammarenaviruses

FAIR Checklist

Authors (11)

Funding (8 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)